Skip to main content
. 2017 Jun 8;1(5):406–420. doi: 10.1002/hep4.1052

Table 2.

DEMOGRAPHICS AND PREOPERATIVE CHARACTERISTICS OF RECIPIENTS CORRELATED WITH RS3761548 GENOTYPE

Variables C/C (n = 67) A/C+A/A (n = 35) P Valuea
Gender 0.0011a
Male 49 (73.13) 14 (40)
Female 18 (26.87) 21 (60)
Age (year) 53.62 ± 9.46 53.11 ± 13.39 0.53
ABO Compatibility 0.15
Compatible 54 (80.60) 32 (91.43)
Incompatible 13 (19.40) 3 (8.57)
Original disease 0.72
HCV 23 (34.33) 14 (40)
HBV 16 (23.88) 5 (14.29)
Autoimmune disease 7 (10.45) 4 (11.43)
Others 21 (31.34) 12 (34.29)
MELD 18.34 ± 8.99 17.88 ± 7.66 0.71
Child‐Turcotte‐Pugh 0.58
A 5 (7.46) 3 (8.57)
B 24 (35.82) 9 (25.71)
C 38 (56.72) 23 (65.71)
Donor 0.74
Parent 3 (4.48) 3 (8.57)
Child 38 (56.72) 21 (60)
Sibling 10(14.93) 4 (11.43)
Spouse 14 (22.90) 7 (20)
Others 2 (2.99) 0 (0)
HLA total mismatches 3.47 ± 1.60 3.57 ± 1.52 0.75
HLA Class I mismatch 2.36 ± 1.18 2.37 ± 1.05 0.93
HLA Class II mismatch 1.10 ± 0.66 1.20 ± 0.71 0.48
GRWR 0.89 ± 0.20 0.91 ± 0.20 0.86

GRWR, graft‐to‐recipient weight ratio; HBV, hepatitis B virus; HCV, hepatitis C virus; LDLT, Living donor liver transplantation; MELD, model for end‐stage liver disease; SD, standard deviation.

Categorical variables are presented as number (%) while continuous variables are presented as mean ± SD.

a

Pearson's chi‐squared test/ Wilcoxon rank sum tests, a difference was considered significant if P‐value was < 0.05.

Typed HLA antigens: HLA‐A1, HLA‐A2, HLA‐B1, HLA‐B2, HLA‐DR1, and HLA‐DR2.